Friedreich’s Ataxia Drug Market Analysis and Trends Driving Rare Disease Therapeutic Innovation
The Friedreich’s Ataxia Drug Market Analysis highlights the increasing focus on developing targeted therapies for rare neurological disorders. Friedreich’s Ataxia is a genetic condition caused by mutations affecting mitochondrial function, leading to progressive nerve damage, muscle weakness, and coordination loss. The limited availability of approved treatments has created a strong...
0 Commentarii 0 Distribuiri 67 Views 0 previzualizare